Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 15;3(1):18.
doi: 10.1186/s42466-021-00113-4.

Post-COVID-19 encephalomyelitis

Ji-Won Kim  1 , Nuran Abdullayev  2 , Janina Neuneier  1 , Gereon R Fink  1   3 , Helmar C Lehmann  4
Affiliations

Post-COVID-19 encephalomyelitis

Ji-Won Kim et al. Neurol Res Pract. .

Abstract

Since the outbreak of coronavirus disease 2019 (COVID-19), a growing number of cases of acute transverse myelitis associated with COVID-19 have been reported. Here, we present the case of a patient who developed sensory ataxia after COVID-19 with MR lesions suggestive for longitudinal myelitis and in the splenium of the corpus callosum. The patient was successfully treated with immunoadsorption.

Keywords: Autoimmunity; Myelitis; Neuromyelitis optica; Postinfectious.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
a Disease course and treatment of the patient. b Axial fluid-attenuated inversion recovery (FLAIR) and c axial diffusion-weighted imaging (DWI) show a hyperintensity in the splenium of the corpus callosum. d Sagittal T2 sequence of the cervical spine shows disc protrusion with spinal canal stenosis at C4-C6. e Postoperative sagittal and f axial T2 images of the cervical spine show a new hyperintensity in the dorsal columns extending from the cranial base to C6/7
See this image and copyright information in PMC

References

    1. Alexopoulos H, Magira E, Bitzogli K, Kafasi N, Vlachoyiannopoulos P, Tzioufas A, Kotanidou A, Dalakas MC. Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome. Neurology-Neuroimmunology Neuroinflammation. 2020;7(6):e893. doi: 10.1212/NXI.0000000000000893. - DOI - PMC - PubMed
    1. Andriuta, D., Roger, P.-A., Thibault, W., Toublanc, B., Sauzay, C., Castelain, S., … Brochot, E. (2020). COVID-19 encephalopathy: Detection of antibodies against SARS-CoV-2 in CSF. Journal of Neurology, 1–2. 10.1007/s00415-020-09975-1. - PMC - PubMed
    1. Hayashi M, Sahashi Y, Baba Y, Okura H, Shimohata T. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion. Journal of the Neurological Sciences. 2020;415:116941. doi: 10.1016/j.jns.2020.116941. - DOI - PMC - PubMed
    1. Krupp LB, Banwell B, Tenembaum S, International Pediatric MS Study Group Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68(16 Suppl 2):S7–S12. doi: 10.1212/01.wnl.0000259422.44235.a8. - DOI - PubMed
    1. Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, Filippi M, Huerga E, Miszkiel KA, Plant GT, Polman C, Rovaris M, Thompson AJ, Montalban X, Miller DH. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: A multicentre retrospective study. Lancet Neurology. 2007;6(8):677–686. doi: 10.1016/S1474-4422(07)70176-X. - DOI - PubMed

LinkOut - more resources